Abstract
The sequence of the first 20 NH2-terminus residues of P30 were obtained from this major surface antigen of T. gondii purified by HPLC. A synthetic peptide (P30 48–67) has been prepared both in linear form and as an octameric construction. Immunization of mice and rats with the P30 48–67 octamer in the presence of IFA induces high levels of IgG antibodies which recognize both the monomelic and the octameric peptides in ELISA, and P30 in Western blots of NP40-extracted tachyzoite antigens. Since these sera are negative in immunofluorescence assays with whole tachyzoites, it seems that IgG antibodies induced by P30 48–67 octamer, although recognizing the denatured structure, are unable to recognize the native protein. The protective effect of both constructs has been studied in mice and Nude rats. Whereas immunization of mice with the monomelic peptide does not confer any protection against oral infection with 1200 cysts of T. gondii 76K strain (mortality within 11 days), 40% of mice immunized with the octameric construct survived up to 75 days after infection. Nude rats were passively transferred with 5 x104 T lymphocytes from P30 48–67 octamer-immunized Fischer rats before infection with 5 x 104 RH strain tachyzoites. When compared to Nude rats transferred with control T lymphocytes, they presented an almost two-fold increase in their mean survival time and raised an intense IgG antibody response against P30. This shows that immunization with P30 48–67 MAP also induces an efficient T cell immune response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benedetto N, C Auriault, F Darcy, D Lando, H Watier, and A Capron. (1991). Effect of IFNy and IL2 treatments in mouse and nude rate infections with Toxoplasma gondii. Eur. Cytokine Net. 2: 107.
Bülow R, and JC Boothroyd. (1991). Protection of mice from fatal Toxoplasma gondii infection by immunization with P30 antigen in liposomes. J. Immunol. 147: 3496.
Burg JL, D Perelman, LH Kasper, PL Ware, and JC Boothroyd. (1988). Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 141: 3584.
Cesbron-Delauw MF, B Guy, G Torpier, RJ Pierce, G. Lenzen, JY Cesbron, H Charif, P Lepage, F Darcy, JP Lecocq, and A Capron. (1989). Molecular characterization of a 23kDa major antigen secreted by Toxoplasma gondii. Proc. Natl. Acad. Sci. USA; 86: 7537.
Chinchilla M, OM Guerrero, and E Solano. (1982). Lack of multiplication of Toxoplasma in macrophages of rats in vitro. J. Parasitol. 68: 952.
Darcy F, G Torpier, MF Cesbron-Delauw, A Decoster, and A Capron. (1992). Diagnostic et prévention de la toxoplasmose: nouvelles approches et perspectives. Gynecol. Internat. 1: 48.
Decoster A, F Darcy, A Caron, and A Capron. (1988). IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet ii: 1104.
Duquesne V, C Auriault, H Gras-Masse, C Boutillon, F Darcy, MF Cesbron- Delauw, A Tartar, and A Capron. (1991). Identification of T, cell epitopes within a 23-kD antigen (P24) of Toxoplasma gondii. Clin. Exp. Immunol. 84: 527.
Gazzinelli RT, FT Hakim, F Hieny, GM Shearer, and A Sher. (1991). Synergistic role of CD4+ and CD8+ T-lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146: 286.
Hakim FT, RT Gazzinelli, E Denkers, S Hieny, GM Shearer, and A Sher. (1991). CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147–2310.
Kasper LH, IA Khan, KH Ely, R Buelow, and JC Boothroyd. (1992). Antigen- specific (P30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii- infected peritoneal macrophages. J. Immunol. 148–1493.
Khan IA, KH Ely, and LH Kasper. (1991). A purified parasite antigen (P30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice. J. Immunol. 147: 3501.
Khan IA, KA Smith, and LH Kasper. (1988). Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J. Immunol. 141: 3600.
Laugier M, and M Quilici. (1970). Intérêt expérimental d’une souche de toxoplasme peu pathogène pour la souris. Ann. Parasitol. Hum. Comp. 45: 389.
Santoro F, D Afchain, R Pierce, JY Cesbron, G Ovlaque, and A Capron. (1985) Serodiagnosis of toxoplasma infection using a purified parasite protein (P30). Clin. Exp. Immunol. 62: 262.
Santoro F, C Auriault, P Leite, F Darcy, and A Capron. (1987). Infection du rat athymique par Toxoplasma gondii. C.R. Acad. Sci. Ser III. 304: 297.
Subauste C, AH Koniaris, and JS Remington. (1991). Murine CD8+ cytotoxic lymphocytes lyse Toxoplasma gondii-infected cells. J. Immunol. 147: 3955.
Suzuki Y, MA Orellana, RD Schreiber, and JS Remington. (1988). Interferon γ: the major mediator of resistance against Toxoplasma gondii. Science. 240: 516.
Suzuki Y, and JS Remington. (1990). The effect of anti-IFN γ antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. J. Immunol. 144: 1954.
Tam JP. (1988). Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci USA. 85: 5409.
Wolowczuk I, C Auriault, M Bossus, D Boulanger, H Gras-Masse, C Mazingue, RJ Pierce, D Grezel, A Tartar, and A Capron. (1991). Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28GST antigen in rat, mouse and monkey. 1 Partial protection of Fischer rat after active immunisation. J. Immunol. 146: 1987.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Darcy, F. et al. (1993). Protection of Mice and Nude Rats Against Toxoplasmosis by an Octameric Construct of the P30 48–67 Peptide. In: Smith, J.E. (eds) Toxoplasmosis. NATO ASI Series, vol 78. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78559-7_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-78559-7_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78561-0
Online ISBN: 978-3-642-78559-7
eBook Packages: Springer Book Archive